Search Results - "Warner, D. T."

Refine Results
  1. 1

    Nucleotide oligomerization domain 1 is a dominant pathway for NOS2 induction in vascular smooth muscle cells: comparison with Toll‐like receptor 4 responses in macrophages by Moreno, L, McMaster, SK, Gatheral, T, Bailey, LK, Harrington, LS, Cartwright, N, Armstrong, PCJ, Warner, TD, Paul‐Clark, M, Mitchell, JA

    Published in British journal of pharmacology (01-08-2010)
    “…Background and purpose:  Gram‐negative bacteria contain ligands for Toll‐like receptor (TLR) 4 and nucleotide oligomerization domain (NOD) 1 receptors…”
    Get full text
    Journal Article
  2. 2

    Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease by Roland, M, Bhowmik, A, Sapsford, R J, Seemungal, T A R, Jeffries, D J, Warner, T D, Wedzicha, J A

    Published in Thorax (01-01-2001)
    “…BACKGROUND Endothelin (ET)-l is a bronchoconstrictor peptide produced in the airways. It has been implicated in the pathogenesis of asthma and virally mediated…”
    Get full text
    Journal Article
  3. 3

    Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapy by Mitchell, Jane A, Warner, Timothy D

    Published in British journal of pharmacology (01-11-1999)
    “…Cyclo‐oxygenase is expressed in cells in two distinct isoforms. Cyclo‐oxygenase‐1 is present constitutively whilst cyclo‐oxygenase‐2 is expressed primarily…”
    Get full text
    Journal Article
  4. 4

    Inhibition of platelet aggregation ex vivo is repressed in apolipoprotein E deficient mice by Carrier, É, Houde, M, Grandbois, M, Bkaily, G, Warner, T D, D'Orléans-Juste, P

    “…In the present study, we assessed whether the endogenous platelet inhibitory mechanisms are altered in the early to moderate stages of the atherosclerotic…”
    Get more information
    Journal Article
  5. 5

    An Open-Label Trial of Evidence-Based Cognitive Behavior Therapy for Nightmares and Insomnia in Crime Victims With PTSD by Krakow, Barry, Johnston, Lisa, Melendrez, Dominic, Hollifield, Michael, Warner, Teddy D., Chavez-Kennedy, Debie, Herlan, Margaret J.

    Published in The American journal of psychiatry (01-12-2001)
    “…OBJECTIVE: Insomnia and nightmares are perceived as secondary phenomena in posttraumatic stress disorder (PTSD). Scant treatment research has targeted these…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Effects of non‐steroidal anti‐inflammatory drugs on cyclo‐oxygenase and lipoxygenase activity in whole blood from aspirin‐sensitive asthmatics vs healthy donors by Gray, P A, Warner, T D, Vojnovic, I, Del Soldato, P, Parikh, A, Scadding, G K, Mitchell, J A

    Published in British journal of pharmacology (01-12-2002)
    “…Cyclo‐oxygenase (COX) and lipoxygenase (LO) share a common substrate, arachidonic acid. Aspirin and related drugs inhibit COX activity. In a subset of patients…”
    Get full text
    Journal Article
  9. 9

    A controlled study of imagery rehearsal for chronic nightmares in sexual assault survivors with PTSD: A preliminary report by Krakow, Barry, Hollifield, Michael, Schrader, Ron, Koss, Mary, Tandberg, Dan, Lauriello, John, McBride, Leslie, Warner, Teddy D., Cheng, Diana, Edmond, Tonya, Kellner, Robert

    Published in Journal of traumatic stress (01-10-2000)
    “…Imagery‐rehearsal therapy for chronic nightmares was assessed in a randomized, controlled study of sexual assault survivors with posttraumatic stress disorder…”
    Get full text
    Journal Article
  10. 10

    Ex vivo assay to determine the cyclooxygenase selectivity of non‐steroidal anti‐inflammatory drugs by Giuliano, Francesco, Warner, Timothy D

    Published in British journal of pharmacology (01-04-1999)
    “…In this study we describe experiments to establish ex vivo the selectivity of non‐steroidal anti‐inflammatory drugs (NSAIDs) given in vivo. Anaesthetised…”
    Get full text
    Journal Article
  11. 11

    In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation by ARMSTRONG, P. C. J., LEADBEATER, P. D., CHAN, M. V., KIRKBY, N. S., JAKUBOWSKI, J. A., MITCHELL, J. A., WARNER, T. D.

    Published in Journal of thrombosis and haemostasis (01-03-2011)
    “…Background: Aspirin and antagonists of platelet ADP P2Y12 receptors are often coprescribed for protection against thrombotic events. However, blockade of…”
    Get full text
    Journal Article
  12. 12

    Selective COX‐2 inhibitors and human inflammatory bowel disease by MCCARTNEY, S. A, MITCHELL, J. A, FAIRCLOUGH, P. D, FARTHING, M. J. G, WARNER, T. D

    Published in Alimentary pharmacology & therapeutics (01-08-1999)
    “…Background : Much recent effort has been made to produce selective inhibitors of cyclo‐oxygenase‐2 (COX‐2) in the belief that these will lack the…”
    Get full text
    Journal Article
  13. 13

    Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages by Schmidt, H H, Warner, T D, Nakane, M, Förstermann, U, Murad, F

    Published in Molecular pharmacology (01-04-1992)
    “…In nitrinergic signal transduction, nitrogen oxide (NO) synthases (NOS) (EC 1.14.23) catalyze the conversion of L-arginine to L-citrulline and NO, which in…”
    Get more information
    Journal Article
  14. 14

    Why Neighborhoods (and How We Study Them) Matter for Adolescent Development by Warner, T D, Settersten, Jr, R A

    Published in Advances in child development and behavior (01-01-2017)
    “…Adolescence is a sensitive developmental period marked by significant changes that unfold across multiple contexts. As a central context of development,…”
    Get more information
    Journal Article
  15. 15

    Platelet responses to pharmacological and physiological interventions in middle‐aged men with different habitual physical activity levels by Lundberg Slingsby, M. H., Gliemann, L., Thrane, M., Rytter, N., Egelund, J., Chan, M. V., Armstrong, P. C., Warner, T. D., Hellsten, Y.

    Published in Acta Physiologica (01-05-2018)
    “…The current guidelines following an acute coronary syndrome recommend dual‐antiplatelet therapy (DAPT) (aspirin plus a P2Y12 antagonist) alongside lifestyle…”
    Get full text
    Journal Article
  16. 16

    Perspectives of Patients With Schizophrenia and Psychiatrists Regarding Ethically Important Aspects of Research Participation by Roberts, Laura Weiss, Warner, Teddy D., Brody, Janet L.

    Published in The American journal of psychiatry (01-01-2000)
    “…OBJECTIVE: Significant controversy surrounds the ethics of psychiatric research. Nevertheless, few data have been gathered to improve our understanding of how…”
    Get full text
    Journal Article
  17. 17

    Pharmacological assessment of ibuprofen arginate on platelet aggregation and colon cancer cell killing by Ahmetaj-Shala, B., Tesfai, A., Constantinou, C., Leszczynski, R., Chan, M.V., Gashaw, H., Galaris, G., Mazi, S., Warner, T.D., Kirkby, N.S., Mitchell, J.A.

    “…Nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, are amongst the most commonly used medications and produce their anti-inflammatory and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Nomenclature for COX-2 Inhibitors by Vane, JR, Warner, TD

    Published in The Lancet (British edition) (21-10-2000)
    “…Patrignani and colleagues' human in-vitro wholeblood assay5 has become an accepted and reproducible standard for measuring the effects of anti-inflammatory…”
    Get full text
    Journal Article
  20. 20